Quarterly report pursuant to Section 13 or 15(d)

Document and Entity Information

v3.10.0.1
Document and Entity Information - shares
9 Months Ended
Sep. 30, 2018
Nov. 06, 2018
Document And Entity Information    
Entity Registrant Name Matinas BioPharma Holdings, Inc.  
Entity Central Index Key 0001582554  
Document Type 10-Q  
Document Period End Date Sep. 30, 2018  
Amendment Flag false  
Current Fiscal Year End Date --12-31  
Entity Filer Category Accelerated Filer  
Entity Small Business Flag false  
Entity Emerging Growth Company true  
Entity Ex Transition Period true  
Entity Common Stock, Shares Outstanding   112,385,590
Trading Symbol MTNB  
Document Fiscal Period Focus Q3  
Document Fiscal Year Focus 2018